Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells

Cancer Letters

Volumn 320, Issue 2, 2012, Pages 198-204

  Lau, Man Tat ^a   So, Wai Kin ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

EGF; ITGB1; MAPK ERK; Ovarian cancer

Indexed keywords

BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL; CELL INVASION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD29; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; UP-REGULATION;

EID: 84859625971     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.02.028     Document Type: Article

References (29)

1. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
2. Guo W., Giancotti F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 2004, 5:816-826.
3. Mitra S.K., Schlaepfer D.D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 2006, 18:516-523.
4. Dong Y., Tan O.L., Loessner D., Stephens C., Walpole C., Boyle G.M., Parsons P.G., Clements J.A. Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res. 2010, 70:2624-2633.
5. Li Q., Liu S., Lin B., Yan L., Wang Y., Wang C., Zhang S. Expression and correlation of Lewis y antigen and integrins alpha5 and beta1 in ovarian serous and mucinous carcinoma. Int. J. Gynecol. Cancer 2010, 20:1482-1489.
6. Casey R.C., Skubitz A.P. CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin. Exp. Metastas. 2000, 18:67-75.
7. Ellerbroek S.M., Fishman D.A., Kearns A.S., Bafetti L.M., Stack M.S. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Res. 1999, 59:1635-1641.
8. Lessan K., Aguiar D.J., Oegema T., Siebenson L., Skubitz A.P. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am. J. Pathol. 1999, 154:1525-1537.
9. Slack-Davis J.K., Atkins K.A., Harrer C., Hershey E.D., Conaway M. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res. 2009, 69:1469-1476.
10. Lafky J.M., Wilken J.A., Baron A.T., Maihle N.J. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim. Biophys. Acta 2008, 1785:232-265.
11. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv. Cancer Res. 2000, 78:31-101.
12. El-Rayes B.F., LoRusso P.M. Targeting the epidermal growth factor receptor. Brit. J. Cancer 2004, 91:418-424.
13. Marmor M.D., Skaria K.B., Yarden Y. Signal transduction and oncogenesis by ErbB/HER receptors. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:903-913.
14. Psyrri A., Kassar M., Yu Z., Bamias A., Weinberger P.M., Markakis S., Kowalski D., Camp R.L., Rimm D.L., Dimopoulos M.A. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin. Cancer Res. 2005, 11:8637-8643.
15. Lassus H., Sihto H., Leminen A., Joensuu H., Isola J., Nupponen N.N., Butzow R. Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma. J. Mol. Med. 2006, 84:671-681.
16. Mendelsohn J., Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J. Clin. Oncol. 2003, 21:2787-2799.
17. Bartlett J.M., Langdon S.P., Simpson B.J., Stewart M., Katsaros D., Sismondi P., Love S., Scott W.N., Williams A.R., Lessells A.M., Macleod K.G., Smyth J.F., Miller W.R. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Brit. J. Cancer 1996, 73:301-306.
18. Suzuki Y., Yanagisawa M., Yagi H., Nakatani Y., Yu R.K. Involvement of beta1-integrin up-regulation in basic fibroblast growth factor- and epidermal growth factor-induced proliferation of mouse neuroepithelial cells. J. Biol. Chem. 2010, 285:18443-18451.
19. Colomiere M., Findlay J., Ackland L., Ahmed N. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin. Int. J. Biochem. Cell Biol. 2009, 41:1034-1045.
20. Giancotti F.G., Ruoslahti E. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990, 60:849-859.
21. Nicosia S.V., Bai W., Cheng J.Q., Coppola D., Kruk P.A. Oncogenic pathways implicated in ovarian epithelial cancer. Hematol. Oncol. Clin. North Am. 2003, 17:927-943.
22. Neal C.L., McKeithen D., Odero-Marah V.A. Snail negatively regulates cell adhesion to extracellular matrix and integrin expression via the MAPK pathway in prostate cancer cells. Cell Adhes. Migr. 2011, 5:249-257.
23. Jin H., Lanning N.J., Carter-Su C. JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells. Mol. Endocrinol. 2008, 22:1825-1841.
24. Morello V., Cabodi S., Sigismund S., Camacho-Leal M.P., Repetto D., Volante M., Papotti M., Turco E., Defilippi P. Beta1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. Oncogene 2011, 4087-4097.
25. Cordes N., Park C.C. Beta1 integrin as a molecular therapeutic target. Int. J. Radiat. Biol. 2007, 83:753-760.
26. Mitra A.K., Sawada K., Tiwari P., Mui K., Gwin K., Lengyel E. Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 2011, 30:1566-1576.
27. Kren A., Baeriswyl V., Lehembre F., Wunderlin C., Strittmatter K., Antoniadis H., Fassler R., Cavallaro U., Christofori G. Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J. 2007, 26:2832-2842.
28. Cheng J.C., Klausen C., Leung P.C. Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells. Mol. Endocrinol. 2010, 24:1569-1580.
29. Ahmed N., Riley C., Oliva K., Rice G., Quinn M. Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Brit. J. Cancer 2005, 92:1475-1485.